First Trust Cloud Computing ETF vs Tempus AI — how do they compare? First Trust Cloud Computing ETF trades at $170.82 (market cap $3.47B), while Tempus AI trades at $70.28 (market cap $12.58B). The key difference: Tempus AI is far larger — about 3.6× First Trust Cloud Computing ETF's market cap, and First Trust Cloud Computing ETF is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold First Trust Cloud Computing ETF for 84 Days and Tempus AI for 22 Days on average.
| SKYY | TEM | |
|---|---|---|
Market Cap | $3.47B | $12.58B |
Volume | 176,159 | 7,444,569 |
52-Week High | $171.01 | $99.28 |
52-Week Low | $104.16 | $41.55 |
Typical Hold Time | 84 Days | 22 Days |
Sector | — | Broad Market / Factor |
Enterprise Value | — | $13.21B |
Signals from Pluang's Aura AI — not financial advice
SKYY, the First Trust Cloud Computing ETF, trades at $170.78, near its 52-week high, with a slight daily decline of 0.13%. Technical indicators show a bullish trend from moving averages, while oscillators are neutral. Recent news highlights the ETF reaching new highs, driven by AI and cloud computing demand, with institutional adjustments in holdings. Financial ratios are not applicable as this is an ETF tracking a basket of cloud computing stocks.
The outlook for SKYY is positive, supported by secular trends in AI adoption and cloud infrastructure spending. Risks include market volatility and sector concentration, but the ETF offers diversified exposure without heavy reliance on mega-cap tech. Analyst sentiment is generally favorable, focusing on long-term growth opportunities in the cloud computing sector.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is designed to track the performance of companies involved in the cloud computing industry.
Read more on SKYY →Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →